Collectively, these results suggest that LncRNA-ROR acts as an oncogenic molecule in breast cancer, in part by inhibiting miR-205-5p and promoting the EMT process by enhancing the expression of ZEB1 and ZEB2 transcription factors, contributing to breast cancer cell invasion as well as tamoxifen resistance (Figure 2). Here, ZEB2 is linked to breast carcinoma.